Daniele De Pasquale

Daniele De Pasquale

Auto-generated profile, based on publicly available information

Daniele De Pasquale

Smart Bio‐Interfaces Istituto Italiano di Tecnologia Viale Rinaldo Piaggio 34 56025 Pontedera Italy

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2020 in Materials & Design
Verified
Journal Article
Open access
DPDaniele De Pasquale
Daniele De Pasquale
AMAttilio Marino
Attilio Marino
CTChristos Tapeinos
Christos Tapeinos
CPCarlotta Pucci
Carlotta Pucci
SRSilvia Rocchiccioli
Silvia Rocchiccioli
GCGianni Ciofani
Gianni Ciofani
Glioblastoma multiforme (GBM) is one of the most aggressive types of brain cancer, characterized by rapid progression, resistance to treatments, and low survival rates; the development of a targeted treatment for this disease is still today an unattained objective. Among the different strategies developed in the latest few years for the targeted delivery of nanotherapeutics, homotypic membrane-membrane recognition is one of the most promising and efficient. In this work, we present an innovative drug-loaded nanocarrier with improved targeting properties based on the homotypic recognition of GBM cells. The developed nanoplatform consists of boron nitride nanotubes (BNNTs) loaded with doxorubicin (Dox) and coated with cell membranes (CM) extracted from GBM cells (Dox-CM-BNNTs). We demonstrated as Dox-CM-BNNTs are able to specifically target and kill GBM cells in vitro, leaving unaffected healthy brain cells, upon successful crossing an in vitro blood-brain barrier model. The excellent targeting performances of the nanoplatform can be ascribed to the protein component of the membrane coating, and proteomic analysis of differently expressed membrane proteins present on the CM of GBM cells and of healthy astrocytes allowed the identification of potential candidates involved in the process of homotypic cancer cell recognition.

27 May 2020 in ACS Applied Materials & Interfaces
Verified
Journal Article
Open access
CPCarlotta Pucci
Carlotta Pucci
DPDaniele De Pasquale
Daniele De Pasquale
AMAttilio Marino
Attilio Marino
CMChiara Martinelli
Chiara Martinelli
SLSimone Lauciello
Simone Lauciello
GCGianni Ciofani
Gianni Ciofani
Glioblastoma multiforme is the most aggressive brain tumor due to its high invasiveness and genetic heterogeneity. Moreover, the blood-brain barrier prevents many drugs from reaching a therapeutic concentration at the tumor site, and most of the chemotherapeutics lacks in specificity towards cancer cells, accumulating in both healthy and diseased tissues, with severe side effects. Here, we present in vitro investigations on lipid-based nanovectors encapsulating a drug, nutlin-3a, and superparamagnetic iron oxide nanoparticles, to combine the pro-apoptotic action of the drug and the hyperthermia mediated by superparamagnetic iron oxide nanoparticles stimulated with an alternating magnetic field. The nanovectors are functionalized with the peptide angiopep-2 to target a receptor overexpressed in glioma cells, and to induce receptor-mediated transcytosis through the blood-brain barrier. The glioblastoma multiforme targeting efficiency and the blood-brain barrier crossing abilities were tested through in vitro fluidic models, where different human cell lines were placed to mimic the tumor microenvironment. These nanovectors successfully cross the blood-brain barrier model, maintaining their targeting abilities for glioblastoma multiforme with minimal interaction with healthy cells. Moreover, we showed that nanovector-assisted hyperthermia induces a lysosomal membrane permeabilization that not only initiates a caspase-dependent apoptotic pathway, yet also enhances the anticancer efficacy of the drug.

26 July 2024 in ACS Applied Materials & Interfaces
Verified
Journal Article
Open access
MEMelis Emanet
Melis Emanet
MLMarie Celine Lefevre
Marie Celine Lefevre
MCMaria Cristina Ceccarelli
Maria Cristina Ceccarelli
MBMatteo Battaglini
Matteo Battaglini
ACAlessio Carmignani
Alessio Carmignani
GCGianni Ciofani
Gianni Ciofani
Polydopamine nanoparticles (PDA NPs) are proposed as an anti-cancer tool against hepatocellular carcinoma through the combination of near-infrared (NIR)-mediated hyperthermia and loading with a chemotherapeutic drug, sorafenib (SRF). Cell membranes isolated from a liver cancer cell line (HepG2) have been exploited for the coating of the nanoparticles (thus obtaining CM-SRF-PDA NPs), to promote homotypic targeting toward cancer cells. The selective targeting ability and the combined photothermal and chemotherapeutic activity of the CM-SRF-PDA NPs following NIR irradiation have been evaluated on cell cultures in static and dynamic conditions, besides three-dimensional culture models. Eventually, the therapeutic effectiveness of the proposed approach has also been tested ex ovo on HepG2 spheroid-grafted quail embryos. This comprehensive investigation, supported by proteomic analysis, showed the effectiveness of the proposed nanoplatform and strongly suggests further pre-clinical testing in the treatment of liver cancer.

24 July 2023 in APL Bioengineering
Verified
Journal Article
Open access
PDF file
AMAttilio Marino
Attilio Marino
MBMatteo Battaglini
Matteo Battaglini
ACAlessio Carmignani
Alessio Carmignani
FPFrancesca Pignatelli
Francesca Pignatelli
DPDaniele De Pasquale
Daniele De Pasquale
GCGianni Ciofani
Gianni Ciofani
In recent years, the need for highly predictive brain cancer models to test new anticancer compounds and experimental therapeutic approaches has significantly increased. Realistic in vitro brain tumor-on-a-chip platforms would allow a more accurate selection of valid candidate drugs and nanomedicines, therefore alleviating the economic and ethical issues of unsuccessful studies in vivo. Here, we present a multi-functional self-assembled brain tumor-on-a-chip model characterized by 3D glioma cultures interfaced both to nonmalignant brain cells of the peritumoral niche and to a 3D-real-scale blood–brain barrier (BBB) microfluidic system. This platform allowed us to screen multiple features, such as BBB crossing capabilities, apoptotic efficacy against GBM cells, and side effects on nonmalignant brain cells of a promising anticancer drug, nutlin-3a, which is fundamental for the treatment of brain cancer.

2 May 2023 in Advanced Healthcare Materials
Verified
Journal Article
Open access
DPDaniele De Pasquale
Daniele De Pasquale
CPCarlotta Pucci
Carlotta Pucci
ADAndrea Desii
Andrea Desii
AMAttilio Marino
Attilio Marino
DDDoriana Debellis
Doriana Debellis
GCGianni Ciofani
Gianni Ciofani
Glioblastoma multiforme (GBM) is the deadliest brain tumor, characterized by an extreme genotypic and phenotypic variability, besides a high infiltrative nature in healthy tissues. Apart from very invasive surgical procedures, to date, there are no effective treatments, and life expectancy is very limited. In this work, an innovative therapeutic approach based on lipid‐based magnetic nanovectors is proposed, owning a dual therapeutic function: chemotherapy, thanks to an antineoplastic drug (regorafenib) loaded in the core, and localized magnetic hyperthermia, thanks to the presence of iron oxide nanoparticles, remotely activated by an alternating magnetic field. The drug is selected based on ad hoc patient‐specific screenings; moreover, the nanovector is decorated with cell membranes derived from patients’ cells, aiming at increasing homotypic and personalized targeting. It is demonstrated that this functionalization not only enhances the selectivity of the nanovectors toward patient‐derived GBM cells, but also their blood–brain barrier in vitro crossing ability. The localized magnetic hyperthermia induces both thermal and oxidative intracellular stress that lead to lysosomal membrane permeabilization and to the release of proteolytic enzymes into the cytosol. Collected results show that hyperthermia and chemotherapy work in synergy to reduce GBM cell invasion properties, to induce intracellular damage and, eventually, to prompt cellular death.

5 December 2023 in ACS Applied Materials & Interfaces
Verified
Journal Article
Open access
ÖŞÖzlem Şen
Özlem Şen
MEMelis Emanet
Melis Emanet
MMMartina Mazzuferi
Martina Mazzuferi
MBMartina Bartolucci
Martina Bartolucci
FCfederico Catalano
federico Catalano
GCGianni Ciofani
Gianni Ciofani
Microglial cells play a critical role in glioblastoma multiforme (GBM) progression, which is considered a highly malignant brain cancer. The activation of microglia can either promote or inhibit GBM growth depending on the stage of the tumor development and on the microenvironment conditions. The current treatments for GBM have limited efficacy; therefore, there is an urgent need to develop novel and efficient strategies for drug delivery and targeting: in this context, a promising strategy consists of using nanoplatforms. This study investigates the microglial response and the therapeutic efficacy of dual-cell membrane-coated and doxorubicin-loaded hexagonal boron nitride nanoflakes tested on human microglia and GBM cells. Obtained results show promising therapeutic effects on glioma cells and an M2 microglia polarization, which refers to a specific phenotype or activation state that is associated with anti-inflammatory and tissue repair functions, highlighted through proteomic analysis.